CN114058565A - 一种无血清的黑素母细胞培养液及其培养方法 - Google Patents
一种无血清的黑素母细胞培养液及其培养方法 Download PDFInfo
- Publication number
- CN114058565A CN114058565A CN202010759942.3A CN202010759942A CN114058565A CN 114058565 A CN114058565 A CN 114058565A CN 202010759942 A CN202010759942 A CN 202010759942A CN 114058565 A CN114058565 A CN 114058565A
- Authority
- CN
- China
- Prior art keywords
- melanoblast
- culture solution
- culture
- serum
- free
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003866 melanoblast Anatomy 0.000 title claims abstract description 130
- 238000012136 culture method Methods 0.000 title abstract description 8
- 239000006285 cell suspension Substances 0.000 claims abstract description 25
- 210000004027 cell Anatomy 0.000 claims abstract description 19
- 239000000654 additive Substances 0.000 claims abstract description 18
- 230000000996 additive effect Effects 0.000 claims abstract description 12
- 150000001413 amino acids Chemical class 0.000 claims abstract description 8
- 229940088594 vitamin Drugs 0.000 claims abstract description 8
- 229930003231 vitamin Natural products 0.000 claims abstract description 8
- 235000013343 vitamin Nutrition 0.000 claims abstract description 8
- 239000011782 vitamin Substances 0.000 claims abstract description 8
- 238000000338 in vitro Methods 0.000 claims abstract description 7
- 239000000243 solution Substances 0.000 claims description 87
- 210000001519 tissue Anatomy 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 17
- 238000012258 culturing Methods 0.000 claims description 15
- 210000003953 foreskin Anatomy 0.000 claims description 13
- 230000009089 cytolysis Effects 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 6
- OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 claims description 5
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 claims description 5
- 239000007853 buffer solution Substances 0.000 claims description 5
- 230000001079 digestive effect Effects 0.000 claims description 5
- 239000012154 double-distilled water Substances 0.000 claims description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 5
- 230000006870 function Effects 0.000 claims description 5
- 238000011534 incubation Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 102000004142 Trypsin Human genes 0.000 claims description 4
- 108090000631 Trypsin Proteins 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000012588 trypsin Substances 0.000 claims description 4
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 229960003531 phenolsulfonphthalein Drugs 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 238000000354 decomposition reaction Methods 0.000 claims 1
- 210000005081 epithelial layer Anatomy 0.000 claims 1
- 238000010008 shearing Methods 0.000 claims 1
- 238000009966 trimming Methods 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 abstract description 6
- 229910017053 inorganic salt Inorganic materials 0.000 abstract description 4
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 4
- 230000003915 cell function Effects 0.000 abstract description 3
- 210000002966 serum Anatomy 0.000 abstract description 3
- 241000204031 Mycoplasma Species 0.000 abstract description 2
- 241000700605 Viruses Species 0.000 abstract description 2
- 239000012894 fetal calf serum Substances 0.000 abstract description 2
- 230000002934 lysing effect Effects 0.000 abstract 1
- 210000002752 melanocyte Anatomy 0.000 description 36
- 239000001963 growth medium Substances 0.000 description 17
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 16
- 210000000981 epithelium Anatomy 0.000 description 12
- 238000004113 cell culture Methods 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 9
- 108010007093 dispase Proteins 0.000 description 8
- 230000035755 proliferation Effects 0.000 description 7
- 102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 description 5
- 210000000130 stem cell Anatomy 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 4
- 210000004207 dermis Anatomy 0.000 description 4
- 230000008099 melanin synthesis Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 208000017520 skin disease Diseases 0.000 description 4
- 102100031413 L-dopachrome tautomerase Human genes 0.000 description 3
- 102000013760 Microphthalmia-Associated Transcription Factor Human genes 0.000 description 3
- 108010050345 Microphthalmia-Associated Transcription Factor Proteins 0.000 description 3
- 238000007664 blowing Methods 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 238000010166 immunofluorescence Methods 0.000 description 3
- 238000012606 in vitro cell culture Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 201000001441 melanoma Diseases 0.000 description 3
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 2
- 206010008570 Chloasma Diseases 0.000 description 2
- 101000773083 Homo sapiens 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 2
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 101100154912 Mus musculus Tyrp1 gene Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 208000030381 cutaneous melanoma Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000002267 hypothalamic effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 201000003708 skin melanoma Diseases 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
- C12N5/0626—Melanocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/14—Calcium; Ca chelators; Calcitonin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/16—Magnesium; Mg chelators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/22—Zinc; Zn chelators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/35—Polyols, e.g. glycerin, inositol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/40—Nucleotides, nucleosides, bases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/46—Amines, e.g. putrescine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/365—Endothelin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010759942.3A CN114058565A (zh) | 2020-07-31 | 2020-07-31 | 一种无血清的黑素母细胞培养液及其培养方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010759942.3A CN114058565A (zh) | 2020-07-31 | 2020-07-31 | 一种无血清的黑素母细胞培养液及其培养方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114058565A true CN114058565A (zh) | 2022-02-18 |
Family
ID=80227682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010759942.3A Pending CN114058565A (zh) | 2020-07-31 | 2020-07-31 | 一种无血清的黑素母细胞培养液及其培养方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114058565A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1205737A (zh) * | 1995-12-21 | 1999-01-20 | 雀巢制品公司 | 改良无限增殖化人类皮肤细胞系和用于其生产的新型无血清培育基 |
CN105112355A (zh) * | 2015-09-07 | 2015-12-02 | 北京艾美特夫生物科技有限公司 | 一种黑色素细胞的培养方法 |
WO2017064672A1 (en) * | 2015-10-14 | 2017-04-20 | Cells For Cells, S.P.A. | A method and composition to differentiate mesenchymal stem cells into melanocytes |
JP2017104085A (ja) * | 2015-12-11 | 2017-06-15 | 国立大学法人神戸大学 | 色素幹細胞の製造方法 |
CN108192856A (zh) * | 2017-12-27 | 2018-06-22 | 山东大学 | 一种高效分离和培养人原代黑色素细胞的方法 |
-
2020
- 2020-07-31 CN CN202010759942.3A patent/CN114058565A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1205737A (zh) * | 1995-12-21 | 1999-01-20 | 雀巢制品公司 | 改良无限增殖化人类皮肤细胞系和用于其生产的新型无血清培育基 |
CN105112355A (zh) * | 2015-09-07 | 2015-12-02 | 北京艾美特夫生物科技有限公司 | 一种黑色素细胞的培养方法 |
WO2017064672A1 (en) * | 2015-10-14 | 2017-04-20 | Cells For Cells, S.P.A. | A method and composition to differentiate mesenchymal stem cells into melanocytes |
JP2017104085A (ja) * | 2015-12-11 | 2017-06-15 | 国立大学法人神戸大学 | 色素幹細胞の製造方法 |
CN108192856A (zh) * | 2017-12-27 | 2018-06-22 | 山东大学 | 一种高效分离和培养人原代黑色素细胞的方法 |
Non-Patent Citations (3)
Title |
---|
TOMOHISA HIROBE等: "Basic fibroblast growth factor stimulates the sustained proliferation of mouse epidermal melanoblasts in a serum-free medium in the presence of dibutyryl cyclic AMP and keratinocytes", DEVELOPMENT, vol. 114, pages 439 - 440 * |
TOMOHISA HIROBE等: "控制黑色素细胞生命周期的信息传递物质鉴定与在其美白技术上的展望", 第八届中国化妆品学术研讨会论文集, pages 121 - 146 * |
彭志英: "食品生物技术", 华中科技大学出版社, pages: 180 - 181 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20110217385A1 (en) | Method for extracting mesenchymal stem cell from human or animal embryo and for extracting the secretion product thereof | |
CN110269833A (zh) | 一种脐带间充质干细胞制剂及其制备方法和应用 | |
US20230227786A1 (en) | PREPARATION METHOD AND RECOVERY METHOD OF PARIDUVAL MESENCHYMAL STEM CELLS (PMSCs) | |
US20220325247A1 (en) | METHOD FOR PROMOTING GROWTH OF PARIETAL DECIDUAL BASALIS-MESENCHYMAL STEM CELLS (PDB-MSCs) | |
EP3147352B1 (en) | Method for preparing induced pluripotency stem cells from mesenchymal stem cells by using phlorotannin fraction | |
JP4550582B2 (ja) | 毛髪誘導細胞の培養 | |
CN113509431A (zh) | 一种间充质干细胞提取物及其提取方法和应用 | |
CN114561358B (zh) | 一种提高细胞慢病毒感染率的增强感染培养基及方法 | |
CN105154388B (zh) | 一种皮肤角质细胞分离、培养方法 | |
CN105238739A (zh) | 临床治疗级细胞治疗用黑色素细胞(melanocytes)规模化制备人类细胞外基质筛选培养方法 | |
CN114058565A (zh) | 一种无血清的黑素母细胞培养液及其培养方法 | |
CN116024159A (zh) | 构建鼠类皮肤类器官的方法 | |
CN112608947B (zh) | 一种永生化人皮脂腺细胞系的构建方法及其应用 | |
Huang et al. | A novel primary culture method for rat choroidal epithelial cells | |
CN113621555A (zh) | 一种皮肤成纤维细胞的制备方法 | |
KR101590615B1 (ko) | 돼지 정원줄기세포를 체외 배양하기 위한 배양액 조성물 및 배양방법 | |
CN113373108A (zh) | 一种表皮干细胞扩增培养基及其制备方法和应用 | |
KR101010077B1 (ko) | 미분화 인간배아줄기세포 유래 배양 조성물을 이용한 소 난자의 체외 배양 방법 | |
CN102344904B (zh) | 一种猪细胞培养基 | |
WO2018179374A1 (ja) | 真皮線維芽細胞の培養上清液を含む化粧用組成物およびその製造方法 | |
Trifillis et al. | Culture and characterization of normal epithelium from cystoscopic biopsies of human bladder | |
RU2392318C1 (ru) | Способ получения стабильных клеточных культур | |
Kitala et al. | Isolation, culturing and preparation for transplantation of amniotic mesenchymal stem cells Repetitive and reproducible laboratory, technical protocol. | |
JPH06169761A (ja) | 動物由来線維芽細胞の無血清培養用培地及び培養方法 | |
JP4348458B2 (ja) | 無血清初期胚培養液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Zeng Xuanhao Inventor after: Xu Jinhua Inventor after: Wu Fuyue Inventor after: He Zhendong Inventor before: Zeng Xuanhao Inventor before: Xu Jinhua Inventor before: Wu Fuyue Inventor before: He Zhendong |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240201 Address after: Room 2031-2033, building 201, Chunfang Road, Pudong New Area, China Applicant after: SHANGHAI SHANGRUI BIOLOGICAL PHARMACEUTICAL Co.,Ltd. Country or region after: China Applicant after: SHANGHAI REMED BIOTECHNOLOGY CO.,LTD. Applicant after: HUASHAN HOSPITAL, FUDAN University Address before: Room 2031-2033, building 201, Chunfang Road, Pudong New Area, China Applicant before: SHANGHAI SHANGRUI BIOLOGICAL PHARMACEUTICAL Co.,Ltd. Country or region before: China Applicant before: SHANGHAI REMED BIOTECHNOLOGY CO.,LTD. |